GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » PharmaCorp Rx Inc (TSXV:PCRX) » Definitions » Deferred Tax

PharmaCorp Rx (TSXV:PCRX) Deferred Tax : C$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is PharmaCorp Rx Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

PharmaCorp Rx's change in deferred tax for the three months ended in Dec. 2024 was C$0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil.

PharmaCorp Rx Deferred Tax Historical Data

The historical data trend for PharmaCorp Rx's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCorp Rx Deferred Tax Chart

PharmaCorp Rx Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Deferred Tax
- - - -0.14

PharmaCorp Rx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaCorp Rx Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCorp Rx Deferred Tax Related Terms

Thank you for viewing the detailed overview of PharmaCorp Rx's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCorp Rx Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » PharmaCorp Rx Inc (TSXV:PCRX) » Definitions » Deferred Tax
Comparable Companies
XCNQ:AXCP TSX:SLT.U TSXV:XCYT TSXV:PEZM.H TSXV:RLT.P TSXV:POC.P TSXV:HO.P TSXV:LSC.P TSXV:SBO.H XCNQ:GCA.X AACT ANSC AAM EQV NETD GATE CEP CCIX KFII CCIR
Traded in Other Exchanges
N/A
Address
303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1
Website
PharmaCorp Rx Inc foremerly Proton Capital Corp is a Capital Pool Company. The principal business of the company is to identify and evaluate assets or businesses with a view to potentially acquiring them or interest therein by completing a purchase transaction, by exercising an option, or by any concomitant transaction.